Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical Models (Q46175272)
Jump to navigation
Jump to search
scientific article published in May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical Models |
scientific article published in May 2017 |
Statements
Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical Models (English)
1 reference
Daniel Thomas
1 reference
Ravindra Majeti
1 reference
1 May 2017
1 reference
7
1 reference
5
1 reference
459-461
1 reference